Neoadjuvant radiotherapy after chemotherapy for borderline resectable pancreas cancer

被引：0
|
作者：
Asso, R. [1 ]
Gerard, I. [1 ]
Cury, F. [1 ]
Kopek, N. [1 ]
机构：
[1] McGill Univ, Div Radiat Oncol, Hlth Ctr, Montreal, PQ, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2023年 / 182卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-1376
引用
收藏
页码：S1105 / S1105
页数：1
相关论文
共 50 条
  • [1] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC)
    Rose, J. Bart
    Rocha, Flavio G.
    Lin, Bruce S.
    Alseidi, Adnan
    Biehl, Thomas A.
    Moonka, Ravi
    Ryan, John A.
    Traverso, L. William
    Helton, Scott
    Picozzi, Vincent J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Improved outcomes for borderline resectable adenocarcinoma of the pancreas after neoadjuvant chemotherapy in a community cancer center
    Curto, Eric M.
    Kaza, Angela G.
    Sturdevant, David A.
    Tuvin, Daniel M.
    Ganai, Sabha
    Sticca, Robert P.
    [J]. AMERICAN JOURNAL OF SURGERY, 2022, 224 (06): : 1426 - 1431
  • [3] Radiotherapy for Resectable and Borderline Resectable Pancreas Cancer: When and Why?
    Maxwell, Jessica E.
    Katz, Matthew H. G.
    [J]. JOURNAL OF GASTROINTESTINAL SURGERY, 2021, 25 (03) : 843 - 848
  • [4] Radiotherapy for Resectable and Borderline Resectable Pancreas Cancer: When and Why?
    Jessica E. Maxwell
    Matthew H. G. Katz
    [J]. Journal of Gastrointestinal Surgery, 2021, 25 : 843 - 848
  • [5] Pathologic Response to Neoadjuvant Chemotherapy and Chemoradiation in Borderline Resectable Adenocarcinoma of the Pancreas
    Lee, Joon K.
    Ghanem, Ahmed I.
    Burmeister, Charlotte
    Jaratli, Hayan
    Raoufi, Mohammad
    Khan, Gazala
    Dobrosotskaya, Irina
    Kwon, David
    Siddiqui, Farzan
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E4 - E4
  • [6] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    [J]. FRONTIERS IN ONCOLOGY, 2022, 11
  • [7] Neoadjuvant Therapy for Resectable and Borderline Resectable Adenocarcinoma of the Pancreas
    Wolff, Robert A.
    [J]. CURRENT DRUG TARGETS, 2012, 13 (06) : 781 - 788
  • [8] Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
    Nichols, Romaine Charles
    Rutenberg, Michael
    [J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2019, 11 (07): : 303 - 307
  • [9] Neoadjuvant Chemotherapy Efficacy and Safety in Borderline Resectable Pancreatic Cancer
    He, X.
    Zheng, Y.
    Wang, Jiabao
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 62 - 66
  • [10] Extended neoadjuvant chemotherapy (CT) in borderline resectable pancreas cancer (BRPC): Is preoperative chemoradiation (CRT) essential?
    Picozzi, Vincent J.
    Rocha, Flavio G.
    Rose, J. Bart
    Traverso, L. William
    Alseidi, Adnan
    Lin, Bruce S.
    Biehl, Thomas A.
    Ryan, John A.
    Moonka, Ravi
    Helton, Scott
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
12345